The 6th MIT Madrid Symposium, in collaboration with Fundacion Ramon Areces, focuses on the future of mobility. The symposium brings together leading experts and thought leaders in the field, to discuss the latest trends and technologies shaping the future of transportation.
This symposium covers a wide range of topics, including batteries for electric vehicles, electric and hybrid powertrains, shared mobility services, and the impact of emerging technologies on transportation infrastructure and the future of air travel. These experts will also discuss the role of public policy in shaping the future of mobility, with a particular focus on sustainability and accessibility.
Principal Investigator Gaia Stucky de Quay
Contact
Â
From understanding how to respond to entry by entrepreneurial start-ups, to assessing the value of IP, to managing a portfolio of innovation projects, this program provides managers with actionable frameworks to craft a technology strategy that will enable their firm to create, capture, and deliver value.
Leaders of digital enterprises have a unique opportunity to not only transform their businesses, but to help transform their customers as well. What will define great leadership in the new digital economy? What new leadership behaviors are needed, and how can organizations make the behaviors the norm throughout an organization? Digital media and methods are transforming businesses around the world. However, a global study of thousands of companies and C-suite leaders show a startling gap in readiness to compete, let alone win, in this new environment. This new course is designed to help participants define and achieve great leadership for their organizations in the new digital economy.
This research-driven and practitioner-led program is designed to help senior executives avert failure, create cultures of agility and resiliency, and develop a customized blueprint for large-scale transformation in their organization.
This conference will explore new or improved therapeutic approaches for finding cures for diseases which traditionally have been difficult to treat. This includes technologies for optimizing treatments and monitoring efficacy based on insights into cell and tissue state, circuitry, behavior, function, and responsiveness in normal and disease states, biomarker detection, better methods to predict and track efficacy, and enhanced manufacturing capabilities.